TUESDAY, JUNE 14 CONFERENCE DAY 1
Keynote Address
Graham Colditz, DrPH, MD, MPH, Niess-Gain Professor of Surgery, School of Medicine; Associate Director of Prevention and Control, Siteman Cancer Center; and Deputy Director, Institute for Public Health, Washington University in St. Louis
Plenary Session #1
- Lung Cancer Screening Guidelines and the Impact on Cancer Surveillance
Michael LeFevre, MD, MSPH, Co-Vice Chair, U.S. Preventive Services Task Force on Lung Cancer Screening Guidelines/Vice Chair, Family & Community Medicine, University of Missouri School of Medicine - Recording Pediatric Cancer Stage in Population-Based Cancer Registries: The Toronto Consensus Guidelines
A. Lindsay Frazier, MD, Associate Professor of Pediatrics, Harvard Medical School | Dana-Farber Cancer Institute
Plenary Session #2
- Setting the Stage for Diversity
Panel Moderator: Diane L. Adams, MD, MPH, DABCHS, CHS-III, Juxtopia, LLC - Cancer and Mortality Surveillance for American Indian and Alaska Native Populations
Melissa A. Jim, MPH, CDC, Indian Health Service - If You Don’t Ask, You Don’t Count: Including Sexual Orientation and Gender Identity for Cancer Research and Surveillance
Jane A. McElroy, PhD, Associate Professor, Family and Community Medicine, University of Missouri School of Medicine - Training for Diversity in Public Health Practice
Ross C. Brownson, PhD, George Warren Brown School of Social Work, Washington University in St. Louis/President, American College of Epidemiology
NAACCR News
Update on the NAACCR Strategic Management Plan 2016-2021
Antoinette Stroup, PhD, NAACCR President-Elect
Virtual Pooled Registry Project
Castine Clerkin, MS, CTR, NAACCR Program Manager of Virtual Pooled Registry
Concurrent Session #1
01 – Triple Negative Breast Cancer and Factors Associated with Its Treatment in the U.S., 2011–2012 M. Wu, CDC, Atlanta, GA, United States
02 – Triple-Negative Breast Cancer in Georgia: Burden, Disparities, and Connections to Georgia’s Breast Cancer Genomics Program A.K. Berzen, Georgia Department of Public Health, Atlanta, GA, United States
03 – Breast Cancer Incidence in Marin County: A Hotspot Grows Cold? C. Clarke-Dur, Cancer Prevention Institute of California, Fremont, CA, United States
04 – Utilization of Oncotype DX Test for Node-Negative, Hormone Receptor Positive, HER2 Negative Breast Cancers in the Community Setting X.C. Wu, LSU Health Sciences Center, New Orleans, LA, United States
05 – Hispanic Childhood Leukemia Incidence in California: High and Rising B. Giddings, California Cancer Reporting and Epidemiologic Surveillance Program, UC Davis Health System, Institute for Population Health Improvement, Sacramento, CA, United States
06 – On Second Thought, Yes, We Do Have a Prevalence Estimate for Non-Malignant Brain Tumors! C. Kruchko, Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, IL, United States
07 – Trends in the Lifetime Risk of Developing Cancer in Ontario, Canada H. Jiang, Cancer Care Ontario, Toronto, ON, Canada | University of Toronto, Toronto, ON, Canada
08 – Completeness of Required Site-Specific Factors for Brain and CNS Tumors in the Surveillance, Epidemiology and End Results (SEER) 18 Database (2004-2012, Varying) J.S. Barmholtz-Sloan, Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, IL, United States | Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, United States
09 – Using NAACCR XML with Relational Databases I. Hands, Kentucky Cancer Registry, Lexington, KY, United States
10 – NAACCR XML in Action: from the SEER Abstracting Tool to SEER*DMS F. Depry, Information Management Services, Inc., Calverton, MD, United States
11 – How Bridging the Gap between VB6 and .Net Provides Efficiency for Automated Tumor Linkage Procedures in Registry Plus Central Registry Database Software M. Esterly, CDC/NPCR, Atlanta, GA, United States
12 – Florida Physician Claims Processing: From Collection to Implementation G. Levin, Florida Cancer Data System, Miami, FL, United States
13 – Unlocking the Power of Physician Medical Claims M. Hernandez, Florida Cancer Data System, University of Miami, Miami, FL, United States
14 – Assessment of Linkage of SEER Breast Cancer Cases to Oncotype DX Tests V. Petkov, National Cancer Institute, Rockville, MD, United States
15 – Improving Patient Demographics in Epath Reports and Timely Capture of Clinically Diagnosed Cancer Cases by Linkage with Hospitals’ Admission, Discharge, and Transfer (ADT) Data M.A. Lynch, Louisiana Tumor Registry, New Orleans, LA, United States
16 – Probabilistic and Deterministic Data Linkage Between Kentucky Cancer Registry Data and Health Claims Data B. Huang, University of Kentucky, Lexington, Kentucky, United States
17 – Impact of Alternative Data Sources on Projected vs. Actual Case Counts R. Wilson, CDC, Atlanta, GA, United States
18 – Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts C.J. Johnson, Cancer Data Registry of Idaho, Boise, ID, United States
19 – Modelling All-Cause Mortality to Produce Life Tables by Socio-Economic Status for Canadian Provinces D. Spika, London School of Hygiene and Tropical Medicine, London, United Kingdom
20 – Improving the Accuracy of Survival Estimates: Use of the SSA Epidemiology File to Identify Invalid Social Security Numbers P.S. Pinheiro, University of Nevada Las Vegas, School of Community Health Sciences, Las Vegas, NV, United States
S-01 – Incidence and Survival of Childhood Brain Tumors in California, 2004-2012 D. Rodriguez, Cancer Registry of Greater California, Public Health Institute, Sacramento, CA, United States | University of California Davis, Graduate Group in Epidemiology, Davis, CA, United States
S-02 – Progression Risk After Sphincter-Preserving Operations in Rectal Cancer: A Registry-Based Study from Arkhangelsk, Northwest Russia D. Dubovichenko, Northern State Medical University, Arkhangelsk, Russian Federation
S-03 – Survival from Ovarian Cancer by Morphological Subtype: Data on 676,987 Women in 61 Countries M. Matz, Cancer Research UK Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, England
S-04 – Usability Assessment of the Missouri Cancer Registry’s Published InstantAtlas Reports Using Health Professionals A. Ben Ramadan, University of Missouri Informatics Institute, Columbia, MO, United States | Missouri Cancer Registry and Research Center, Columbia, MO, United States | Health Management and Informatics Department/ School of Medicine/ University of MissouriColumbia, Columbia, MO, United States
S-05 – The Association between Insurance Status and Childhood Cancer Survival JM Lee, Brown School, Washington University in St. Louis, St. Louis, MO, United States
S-06 – Incidence of Triple Negative Breast Cancer in New Jersey, 2008-2013 A. Kulkarni, Rutgers School of Public Health, New Brunswick, NJ, United States
S-07 – Multilevel Correlates of In-Hospital Mortality Among Head and Neck Cancer Patients A. Adjei Boakye, Saint Louis University, Saint Louis, MO, United States
S-08 – End-Of-Life Costs of Breast and Cervical Cancer in Missouri’s Medicaid Program A. Bouras, School of Medicine Department of Health Management & Informatics (HMI), University of Missouri-Columbia, Columbia, MO, United States | Office of Social and Economic Data Analysis (OSEDA), University of Missouri-Columbia, Columbia, MO, United States | MU Informatics Institute, Columbia, MO, United States
WEDNESDAY, JUNE 15CONFERENCE DAY 2
Plenary Session #3
- Natural Language Processing to Support Cancer Registries and Cancer Surveillance
Paul A. Fearn, PhD, Director, Biomedical Informatics, Fred Hutchinson Cancer Research Center, Seattle, WA, United States - A New Data Resource for Social Needs
Matthew Kreuter, PhD, MPH, Associate Dean for Public Health; Kahn Family Professor of Public Health; and Senior Scientist, Health Communication Research Laboratory, Washington University in St. Louis - Reducing Geographic Disparities: Can Local Breast Cancer Data Identify Where to Target Screening?
Mario Schootman, PhD, Associate Dean for Research; James R. Kimmey Endowed Chair in Public Health; Professor of Epidemiology and of Health Services Research and Medicine, St. Louis University
Concurrent Session #2
21 – The SEER Virtual Tissue Repository Pilot: Leveraging Population-Based Biospecimens R. Moravec, National Cancer Institute, Rockville, MD, United States
22 – Quality of the KRAS Data in Population-Based Registries for Stage IV Colorectal Cancer Cases M.E. Charlton, University of Iowa College of Public Health, Iowa City, IA, United States | State Health Registry of Iowa, Iowa City, IA, United States
23 – Data Federation – A Cancer Registry and a Biobank D.J. Dale, Princess Margaret Cancer Centre, Toronto, ON, Canada
24 – National Program of Cancer Registries – Advancing E-Cancer Reporting and Registry Operations Project (NPCR-AERRO): Electronic Pathology (Epath) and Biomarker Synoptic Reporting Activities S. Jones, Centers for Disease Control and Prevention, Atlanta, GA, United States
25 – The Future of Cancer Registration in the Era of Electronic Health Records J. Rogers, CDC/NPCR, Atlanta, GA, United States
26 – Electronic Physician Reporting to State Cancer Registries …Present and Future W. Blumenthal, Centers for Disease Control and Prevention, Atlanta, GA, United States
27 – Meaningful Use Cancer Reporting in Maryland: What Do You Mean? C. Groves, Westat, Rockville, MD, United States
28 – Successful Onboarding of Physician Office Data for Meaningful Use Stage 2 Cancer Reporting N. Salahuddin, North Carolina Central Cancer Registry, Raleigh, NC, United States
29 – Development of a Natural Language Processing (NLP) Web Service for Structuring and Standardizing Unstructured Clinical Information S. Jones, Centers for Disease Control and Prevention, Atlanta, GA, United States
30 – Enhancing Capture of Detailed Oral Anticancer Medication Utilization in SEER by Leveraging an External Source of Pharmacy Data Q. Tran, National Cancer Institute, Bethesda, MD, United States
31 – Coordinated Data Development Initiative: Enhancing the Access to and Use of Standardized Treatment Data in Canada C. Louzado, Canadian Partnership Against Cancer, Toronto, ON, Canada
32 – Automated Language Processing of Free Text Medical Reports G. Cernile, Artificial Intelligence in Medicine, Inc., Toronto, ON, Canada
33 – Web Plus Survivorship Module: Where We Are and Where We Are Going A.B. Ryerson, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States
34 – Usage Patterns of a Web-Based Application Integrating Cancer Registry Data Into Survivorship Care Plans R.C. Vanderpool, University of Kentucky College of Public Health, Lexington, KY, United States
35 – Strategies to Maximize Data Quality Improvements and Enhancements W. Roshala, PHI/Cancer Registry of Greater California, Sacramento, CA, United States
36 – Visualizing a World with Less Cancer R. Rycroft, Colorado Central Cancer Registry, Denver, CO, United States
37 – Virtual Pooled Registry Pilot Linkages with Large Cohort Studies C. Clerkin, NAACCR, Springfield, IL, United States
38 – Virtual Pooled Registry Test Linkage Results Using Two Software Systems C. Clerkin, NAACCR, Springfield, IL, United States
39 – Value of a Central Institutional Review Board for Multi-Centered Studies Using the Virtual Pooled Registry S. Stoyanoff, Los Angeles Cancer Surveillance Program, Los Angeles, CA, United States
40 – Value of a Virtual Pooled Registry Process to Improve Data Quality in Central Registries L. Penberthy, NCI, Rockville, MD, United States
New Updates/FORDS Manual Updates
Cancer Surveillance Strategies in the Caribbean
THURSDAY, JUNE 16CONFERENCE DAY 3
Concurrent Session #3
41 – Trends in Colorectal Cancer Incidence in Younger Canadians, 1969-2010 P. De, Cancer Care Ontario, Toronto, ON, Canada
42 – The Risk of Colorectal Cancer is Increasing in Successive Birth Cohorts Since the Early 1950s R. Siegel, American Cancer Society, Atlanta, GA, United States
43 – Geographic Variation of Advanced Stage Colorectal Cancer in California J. Rico, California Department of Public Health/California Cancer Registry, Sacramento, CA, United States
44 – Meaningful Use in Practice: What Reporters Think J. Martin, Virginia Cancer Registry, Richmond, VA, United States
45 – Implementing Cancer Case Reporting from Ambulatory Electronic Health Records A.A. Austin, New York State Cancer Registry, Albany, NY, United States
46 – Assessment of the National Program of Cancer Registries (NPCR) Program Evaluation Instrument (PEI) S. Van Heest, Centers for Disease Control and Prevention, Atlanta, GA, United States
47 – Annual Versus Biennial Mammography Screening and Stage at Diagnosis of Breast Cancer in Illinois T.A. Dolecek, University of Illinois at Chicago, Chicago, IL, United States
48 – Gateway to Information: Using Data Visualization to Create Interactive Profiles for Cancer in Missouri by State Senatorial District J. Jackson-Thompson, Missouri Cancer Registry and Research Center, Columbia, MO, United States | University of Missouri (MU) School of Medicine Department of Health Management & Informatics, Columbia, MO, United States | MU Informatics Institute, Columbia, MO, United States
49 – Breast Cancer Prevention Among American Indian/Alaska Native Women in Missouri M. Taffa, T. Sparks, S. Kloeckner and S. Taluc, Kathryn M. Buder Center for American Indian Studies / Brown School of Social Work, Washington University in St. Louis, St. Louis, MO, United States
50 – NPCR’S TNM Stage Calculator: A Tool for Central Registry Quality Control and Consolidation Assistance J. Seiffert, Northrop Grumman, Atlanta, GA, United States
51 – Comparison of TNM Assigned by Physicians Compared with Registry Reviewer Assigned: Results from a SEER Field Study P. Adamo, National Cancer Institute, Bethesda, MD, United States
52 – A Central Registry Reliability Study to Gauge Visual Editor TNM and Summary Stage Coding SkillsD. Hansen, California Cancer Registry, Sacramento, CA, United States
53 – Evaluation of Directly Coded AJCC Stage Data: One Large State’s Experience M.J. Schymura, New York State Cancer Registry, Albany, NY, United States
54 – Combined T, N, and M Based on Directly Coded Clinical and Pathologic T, N, and M: Evaluation of the Derivation Algorithm and Opportunities for Registrar Education and Computer Edits P. Adamo, National Cancer Institute, Bethesda, MD, United States
55 – Racial and Socio-Economic Disparities in Melanoma Incidence Rates in Georgia: 2000-2011 M. Freeman, CDC, Atlanta, GA, United States | ORISE, Oak Ridge, TN, United States
56 – Cancer-Specific Mortality and Racial Disparities Among Cancer Patients with Diabetes Mellitus C. Lam, National Cancer Institute, Rockville, MD, United States
57 – Survival Trends by Socioeconomic Status, 1998-2011: A Shift in Disparities for Colorectal Cancer Survival D. Holt, Westat, Rockville, MD, United States
58 – Examining Income Disparities in Lung Cancer Incidence, Mortality and Survival in Canada S. Fung, Canadian Partnership Against Cancer, Toronto, ON, Canada
Plenary Session #4
- Integrating Population Sciences into Cancer Center Research
Eduardo J. Simoes, MD, MSc, DLSHTM, MPH, Chair and Health Management and Informatics Alumni; Distinguished Professor, Department of Health Management and Informatics, University of Missouri (MU) School of Medicine - Translating Research into Clinical Practice in Hepatocellular Cancer
Kevin Staveley-O’Carroll, MD, PhD, Chair of the Hugh E. Stephenson Jr., MD, Dept. of Surgery, University of Missouri (MU) School of Medicine and Director of MU’s Ellis Fischel Cancer Center - Future of Cancer Surveillance – CDC Perspective
Chesley Richards, MD, MPH, FACP, Deputy Director, Office of Public Health Scientific Services, CDC
Concurrent Session #4
59 – Contributions of HIV to Non-Hodgkin Lymphoma Mortality in the U.S. (2005-2012) E.A. Engels, National Cancer Institute, Bethesda, MD, United States
60 – HIV Infection Is Associated with Low 5-Year Relative Survival for Cancer Patients in Louisiana X.R. Li, Louisiana Tumor Registry, Epidemiology Program, LSUHSC, New Orleans, LA, United States
61 – Trends in Primary Central Nervous System Lymphoma Incidence and Survival in the U.S. M. Shiels, National Cancer Institute, Rockville, MD, United States
62 – Enhancing Cancer Registry Research Recruitment Through Clinical Trial Applications: A Collaboration Between NJSCR and Clinical Performance Partners, Inc. N. Herman, New Jersey State Cancer Registry, Trenton, NJ, United States | Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States
63 – Accuracy of Self-Reported Cancer Diagnosis from the MY-Health Study Cohort Compared with Participating SEER Cancer Registries N. Herman, New Jersey State Cancer Registry, Trenton, NJ, United States | Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States
64 – New Jersey’s Research Management Solution: Our Gateway to Successful Population Based Cancer Research C.J. Harrell, CJH Consulting, Brighton, UT, United States
65 – Finding “Immortals”: Can Statistical Models Help? D. Nishri, Cancer Care Ontario, Toronto, ON, Canada
66 – Finding “Zombies” in Your Registry Database by Confirming Source Record Vital Status D.K. O’Brien, Alaska Cancer Registry, Anchorage, AK, United States
67 – Utilizing State Databases to Improve Follow-up: The Louisiana Vaccination Experience C. Lefante, Louisiana Tumor Registry, New Orleans, LA, United States | LSU Health Sciences Center; School of Public Health, New Orleans, LA, United States
68 – NAACCR V.16 Edits Metafile Update J. Hofferkamp, CTR, NAACCR, Springfiled, IL, United States
69 – AJCC Cancer Staging Manual, 8th Edition Update D. Gress, AJCC, Chicago, IL, United States
70 – Timing is the Key to AJCC TNM Staging D. Gress, AJCC, Chicago, IL, United States
71 – Trends in the Incidence of Thyroid Cancer, Israel, 1990-2012 B.G. Silverman, Israel National Cancer Registry, Israel Center for Disease Control, Israel Ministry of Health, Tel HaShomer, Israel | School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
72 – Leading Causes of Cancer-Specific Mortality in the Caribbean Region H. Razzaghi, CDC, Atlanta, GA, United States
73 – Subsite of the Colon Cancer and Survival in 2000-2013: A Population-Based Analysis from the Arkhangelsk Oblast, North-Western Russia M.Y. Valkov, Northern State Medical University, Arkhangelsk, Russian Federation | Clinical Oncology Center, Arkhangelsk, Russian Federation
74 – World-Wide Variation in Breast Cancer Survival by Age, Stage and Morphology C. Allemani, London School of Hygiene and Tropical Medicine, London, United Kingdom
Concurrent Session #5
75 – Disparities in Cancer Incidence and Survival Between Indigenous and NonIndigenous Adults in Canada: Follow-up of the 1991 Canadian Census Cohort D. Nishri, Cancer Care Ontario, Toronto, ON, Canada
76 – Cancer Incidence and Mortality Patterns Among Chinese Americans D. Deapen, Los Angeles Cancer Surveillance Program, University of Southern California, Los Angeles, CA, United States
77 – Racial Disparities in Cancer Incidence, Staging, and Survival Among the Oldest Old in the United States J. Krok-Schoen, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States
78 – The Alaska Native Tumor Registry: 45 Years of Cancer Surveillance Among Alaska Native People S.H. Nash, Alaska Native Tribal Health Consortium, Anchorage, AK, United States
79 – Evaluation of Commercial Data Sources for Obtaining Individual Residential Histories for Cancer Research D. Stinchcomb, Westat, Inc., Rockville, MD, United States
80 – Easy Interactive Mapping of Cancer Data Revisited J.E.A. Bartholomew, Geowise Limited, Edinburgh, United Kingdom
81 – Responding to Community Concerns Regarding Cancer Incidence – The Role of the Israel National Cancer Registry B.G. Silverman, Israel National Cancer Registry, Israel Center for Disease Control, Israel Ministry of Health, Tel HaShomer, Israel | School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
82 – Estimating Neighbourhood-Level Behavioural Risk Factor Prevalence from Large Population-Based Surveys: A Bayesian Approach L. Seliske, Cancer Care Ontario, Toronto, ON, Canada
83 – Differences Between Hispanic and Non-Hispanic White Breast Cancer Patients: Molecular Subtypes and Survival R.D. Cress, Public Health Institute, Cancer Registry of Greater California, Sacramento, CA, United States
84 – Socio-Demographic Predictors of Survival Among Acute Myelogenous Leukemia Patients in California, 2003-2012 J. Morgan, Loma Linda University School of Public Health, Loma Linda, CA, United States | SEER Cancer Registry of Greater California, Loma Linda, CA, United States
85 – Invasive Cancer Incidence and Survival — United States, 2012 S. Singh, CDC, Atlanta, GA, United States
86 – Collection of Occupation and Industry Information through National Program of Cancer Registries Comparative Effectiveness Research Study M. Freeman, CDC, Atlanta, GA, United States | ORISE, Oak Ridge, TN, United States
87 – Use of Information Systems to Support NAACCR Death Clearance Standards L. Giljahn, Ohio Department of Health, Columbus, OH, United States
88 – Exploring the Efficacy of Using Disease Index to Improve Cancer Registry Data Completeness and Death Clearance Casefinding in Maryland W. Ross, Westat, Rockville, MD, United States
89 – Text: Can it Reduce Your DCO Burden? Youbetcha! L. Stephenson, Wisconsin Cancer Reporting System, Division of Public Health, Madison, WI, United States
90 – Analysis of External Databases to Ascertain Vital Status S. Van Heest, Centers for Disease Control and Prevention, Atlanta, GA, United States
91 – Sorting Out the Primary Payer Jumble, Part A: The Montana Experience L. Williamson, Montana Central Tumor Registry, Helena, MT, United States
92 – Sorting Out the Primary Payer Jumble, Part B: The U.S. Experience R.L. Sherman, NAACCR, Springfield, IL, United States
93 – Disparities in Quality of Care and Outcomes Among Cancer Patients in California: The Role of Health Insurance and Population Demographics A. Parikh-Patel, California Cancer Reporting and Epidemiologic Surveillance (CalCARES) Program, Institute for Population Health Improvement, UC Davis Health System, Sacramento, CA, United States
94 – Augmenting Kentucky Cancer Registry Data with Medicare, Medicaid and Private Insurance Claims Data B. Huang, University of Kentucky, Lexington, KY, United States
95 – Pitfalls and Opportunities Using Cancer Registry Data for Thyroid Cancer Research M.A. Whiteside, Tennessee Department of Health, Nashville, TN, United States
96 – IASLC 2011 and WHO 2015 Classifications of Lung Adenocarcinomas: Demographic Patterns, Trends, and Implications for Cancer Surveillance S. Negoita, Westat, Rockville, MD, United States
97 – Using Cancer Registry Data to Estimate the Percentage of Melanomas Attributable to UV ExposureM. Watson, CDC, Atlanta, GA, United States
Plenary Session #5
- Palliative Care and End-Of-Life Decision Making: The Impact of Population-Based Cancer Data
Clay Anderson, MD, FACP, NorthCare Hospice & Palliative Care
Late Breaker Session
Using Registry Data; Creating Cancer Control Indicators and the New CINA Public Data Set
Recinda Sherman, PhD, Program Manager of Data Use and Research, NAACCR
Caribbean Hub for the Global Initative for Cancer Registries
Glennis Andall-Brereton, PhD, Epideniologist/Senior Technical Officer, Caribbean Public Health Agency CARPHA
Invitation to 2017 Annual Conference in Albuquerque, New Mexico
